| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/10/2008 | US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 06/10/2008 | US7385042 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384948 Graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 06/10/2008 | US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 06/10/2008 | US7384912 Administering parathyroid hormone-related protein intermittently at a dosage of at least 500 mu g/day for at least one month,to increase bone mass densityat a rate of at least 1% per month; treating osteoporosis |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/10/2008 | CA2427338C Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2286719C Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s |
| 06/05/2008 | WO2008067527A1 Inhibitors of protein tyrosine phosphatase for the treatment of muscle atrophy and related disorders |
| 06/05/2008 | WO2008067219A2 Quinazolinone modulators of tgr5 |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066117A1 Cyclic amine compound |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008065738A1 Bone defect filler, release-controlled carrier, and their production methods |
| 06/05/2008 | WO2008065393A1 Hydantoin derivatives used as mmp inhibitors |
| 06/05/2008 | WO2008065199A1 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 06/05/2008 | WO2008064432A1 Polycyclic molecular compounds |
| 06/05/2008 | WO2008064411A1 Nutritional supplement |
| 06/05/2008 | WO2008035228A3 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof |
| 06/05/2008 | WO2008035206A3 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof |
| 06/05/2008 | WO2008006581A3 Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders |
| 06/05/2008 | WO2008004118A3 Carthamus tinctoris plant extracts for treating osteoporosis and the extraction process thereof |
| 06/05/2008 | WO2007127436A3 Methods and compositions for repairing cartilage |
| 06/05/2008 | WO2006102417A3 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132585 Separate type medical material |
| 06/05/2008 | US20080132554 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 06/05/2008 | US20080132553 Preventing and reversing the formation of advance glycosylation endproducts |
| 06/05/2008 | US20080132536 treatment or prophylaxis of inflammatory or allergic diseases chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, allergic rhinitis or atopic dermatitis; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[1-(2,4-dimethylphenyl)propyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide |
| 06/05/2008 | US20080132528 Kinase inhibitors and methods for using the same |
| 06/05/2008 | US20080132493 Aqueous cyclodextrin-free solution; analgesics, antiinflammatories, antipyretics |
| 06/05/2008 | US20080132481 Use of 3-substituted amino-2-carboxy-substituted indoles or benzo(b)thiophenes or esters thereof that modulate T helper (Th) cells; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections |
| 06/05/2008 | US20080132476 Administering e.g. 17beta-Fluoro-9alpha-vinyl-estra-1,3,5(10)-triene-3,16alpha-diol to treat endometriosis, osteoporosis, or hormone replacement therapy in combination with other drugs |
| 06/05/2008 | US20080132460 Screening for a compound which inhibits p62/ubiquitin binding; detecting the formation of inclusion bodies in neurodegenerative diseases; screening for therapeutic agents that disperse the inclusions |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131521 Methods for Preventing or Treating Bone Disorders |
| 06/05/2008 | US20080131425 Biomolecular coating for implants |
| 06/05/2008 | US20080131412 Isoflavone-containing composition |
| 06/05/2008 | US20080131410 Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 06/05/2008 | US20080131407 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | CA2673483A1 Compositions of chk1 inhibitors |
| 06/05/2008 | CA2670976A1 Cyclic amine compound |
| 06/05/2008 | CA2670166A1 Hydantoin derivatives used as mmp inhibitors |
| 06/05/2008 | CA2669343A1 Nutritional supplement |
| 06/04/2008 | EP1927659A1 Wisp polypeptides and therapeutical applications thereof |
| 06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
| 06/04/2008 | EP1926734A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 06/04/2008 | EP1532134B1 Novel thiophene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 06/04/2008 | EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 06/04/2008 | EP1456357B1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | CN101190311A Method for using decoction containing pinellia tuber, atractylodes macrocephala, cannabis sativa and etc. to treat cervical vertigo caused by cervical spondylosis |
| 06/04/2008 | CN101190294A Traditional Chinese medicine for treating gout disease |
| 06/04/2008 | CN101190293A Traditional Chinese medicine liquid for treating hyperosteogeny |
| 06/04/2008 | CN101190292A Traditional Chinese medicine for treating bone fracture |
| 06/04/2008 | CN101190283A Medicine for treating cervical vertebra disease |
| 06/04/2008 | CN101190280A Use of extract of non-fruit part of prune tree |
| 06/04/2008 | CN101190277A Method for preparing stemmacantha uniflora blood circulation-activating, stasis-removing and wind-damp-expelling wine |
| 06/04/2008 | CN101190273A Traditional Chinese medicine emplastrum for repairing acute and chronic injury |
| 06/04/2008 | CN101190272A Traditional Chinese medicine for treating bony spur and hyperosteogeny |
| 06/04/2008 | CN101190268A Compound medicine for treating cervical spondylosis |
| 06/04/2008 | CN101190267A Medicinal composition for treating cervical vertebra disease |
| 06/04/2008 | CN101190256A Chuanqisan for treating cervical spondylopathy and preparation method |
| 06/04/2008 | CN101190227A Betamethasone chewable tablets for dog or cat |
| 06/04/2008 | CN101190013A Formula of honey crisp-fried bean and processing method |
| 06/04/2008 | CN100391956C Strontium ranelate alpha crystalline form, method for the preparation thereof and pharmaceutical compositions containing said agent |
| 06/04/2008 | CN100391531C Osteo proliferation Chinese medicine preparation for external application |
| 06/04/2008 | CN100391524C Medicine preparation for preventing osteoporosis and preparation thereof |
| 06/04/2008 | CN100391516C Shuihema medicated liquor |
| 06/04/2008 | CN100391512C Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness |
| 06/04/2008 | CN100391497C Nanometer Chinese traditional medicine for treating osteoporosis |
| 06/04/2008 | CN100391490C External used Chinese medicine for treating spondylopathy, and its preparing method |
| 06/04/2008 | CN100391482C Saussurea involucrate powder injection |
| 06/04/2008 | CN100391457C Novel bulleyaconitine A powder injection |
| 06/04/2008 | CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base |
| 06/03/2008 | US7381718 new process for the preparation of a key intermediate |
| 06/03/2008 | US7381429 Hormone replacemnent therapy; menopause, osteoporosis, cardiovascular disorders; stroke; sexual disorders |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381409 Immunoglobulin specific to transforming growth factor binding protein for use as tool in prevention and treatment of osteoporosis and bone disorders |
| 06/03/2008 | CA2467964C Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 05/29/2008 | WO2008064315A1 Tetralin analogs having sphingosine 1-phosphate agonist activity |
| 05/29/2008 | WO2008063424A2 Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 05/29/2008 | WO2008063213A2 Uses and compositions for treatment of psoriatic arthritis |
| 05/29/2008 | WO2008062830A1 Spiroquinone compound and pharmaceutical composition |
| 05/29/2008 | WO2008062740A1 Nitrogenated fused ring compound and use thereof |
| 05/29/2008 | WO2008045564A3 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2007130353A3 Phase 2 inducers, ppar-alpha agonists and related signalling pathways protect cartilage against inflammation, apoptosis and stress |
| 05/29/2008 | WO2007120693A3 Targeted binding agents directed to upar and uses thereof |